Visceral adipose tissue is associated with stricturing Crohn's disease Behavior, fecal calprotectin, and quality of life
<p><strong>Background</strong></p><p>Visceral adipose tissue (VAT) has been proposed to play a pathogenic role in Crohn’s disease (CD); however, prospective clinical data are lacking. The aim was to evaluate whether VAT, beyond body mass index (BMI), is associated with...
Main Authors: | Bryant, R, Schultz, C, Ooi, S, Goess, C, Costello, S, Vincent, A, Schoeman, S, Lim, A, Bartholomeusz, F, Travis, S, Andrews, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2018
|
Similar Items
-
Authors' reply: The association between visceral adipose tissue and stricturing crohn's disease behavior, fecal calprotectin and quality of life
by: Bryant, R, et al.
Published: (2018) -
Obesity in inflammatory bowel disease: Gains in Adiposity despite high prevalence of Myopenia and Osteopenia
by: Bryant, RV, et al.
Published: (2018) -
Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
by: Cristina Romero-Mascarell, et al.
Published: (2022-09-01) -
Effect of the Crohn’s Disease Exclusion Diet (CDED) on the Fecal Calprotectin Level in Children with Active Crohn’s Disease
by: Małgorzata Matuszczyk, et al.
Published: (2022-07-01) -
Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease
by: Junrong Li, et al.
Published: (2023-06-01)